The landscape of Medicare is undergoing a transformative change, driven by the Inflation Reduction Act of 2022 and the Centers...
Strategies to Enhance Collaboration A time-consuming authorization process. Complex claim submission and reimbursement processes. Lack of transparency and communication. These...
In the ever-evolving landscape of American healthcare, one issue remains a constant concern for patients, providers, payers, and policymakers alike—the...
Pharmacy benefit managers (PBMs) have become the hot potato of the healthcare industry that nobody wants to hold. State and...
The financial impact of chronic disease in the U.S. is sobering. According to the Centers for Disease Control (CDC), 90%...
They’re often called the four “pillars” of cancer treatment because of their prevalence. Physicians have used surgery, chemotherapy, radiation therapy,...
Now that the Centers for Medicare & Medicaid Services (CMS) has lowered the boom on payers by dropping the star...
Economists can’t agree if the U.S. is headed for a “soft landing” recession, a hard landing, or no recession at...
While spending on oncology drugs in the U.S. is anticipated to reach $125 billion by 2027, overall drug savings of...
After attending my first AHIP (America’s Health Insurance Plans) national conference, I was struck by the level of engagement and...
According to the American Cancer Society, more than 18 million people in the U.S. have cancer, and many of them...
With the median cost of new oncology drugs over $260,000, it’s no wonder payers continue to look for opportunities to...